Статті в журналах з теми "Pranlukast"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Pranlukast".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
&NA;. "Pranlukast." Reactions Weekly &NA;, no. 695 (April 1998): 11. http://dx.doi.org/10.2165/00128415-199806950-00038.
Повний текст джерела&NA;. "Pranlukast." Reactions Weekly &NA;, no. 743 (March 1999): 11–12. http://dx.doi.org/10.2165/00128415-199907430-00034.
Повний текст джерела&NA;. "Pranlukast." Reactions Weekly &NA;, no. 747 (April 1999): 10. http://dx.doi.org/10.2165/00128415-199907470-00030.
Повний текст джерела&NA;. "Pranlukast." Reactions Weekly &NA;, no. 1138 (February 2007): 23. http://dx.doi.org/10.2165/00128415-200711380-00068.
Повний текст джерелаKeam, Susan J., Katherine A. Lyseng-Williamson, and Karen L. Goa. "Pranlukast." Drugs 63, no. 10 (2003): 991–1019. http://dx.doi.org/10.2165/00003495-200363100-00005.
Повний текст джерела&NA;. "Pranlukast." Reactions Weekly &NA;, no. 865 (August 2001): 11. http://dx.doi.org/10.2165/00128415-200108650-00032.
Повний текст джерела&NA;. "Pranlukast." Reactions Weekly &NA;, no. 876 (November 2001): 10. http://dx.doi.org/10.2165/00128415-200108760-00032.
Повний текст джерела&NA;. "Pranlukast." Reactions Weekly &NA;, no. 987 (February 2004): 13. http://dx.doi.org/10.2165/00128415-200409870-00039.
Повний текст джерелаKubota, Jun, Sho Takahashi, Takayuki Suzuki, Akira Ito, Naoe Akiyama, and Noriko Takahata. "Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection." PLOS ONE 17, no. 5 (May 27, 2022): e0269043. http://dx.doi.org/10.1371/journal.pone.0269043.
Повний текст джерелаFigueroa, Eric E., Meghan Kramer, Kevin Strange, and Jerod S. Denton. "CysLT1 receptor antagonists pranlukast and zafirlukast inhibit LRRC8-mediated volume regulated anion channels independently of the receptor." American Journal of Physiology-Cell Physiology 317, no. 4 (October 1, 2019): C857—C866. http://dx.doi.org/10.1152/ajpcell.00281.2019.
Повний текст джерелаKim, Seo W., Hunam Kim, Yon J. Ryu, Jin H. Lee, Sung S. Shim, Yoo K. Kim, and Jung H. Chang. "Efficacy and Safety of Modified Pranlukast (Prakanon®) Compared with Pranlukast (Onon®): A Randomized, Open-Label, Crossover Study." Open Respiratory Medicine Journal 10, no. 1 (June 30, 2016): 36–45. http://dx.doi.org/10.2174/1874306401610010036.
Повний текст джерела&NA;. "Montelukast/pranlukast/zafirlukast." Reactions Weekly &NA;, no. 967 (September 2003): 12. http://dx.doi.org/10.2165/00128415-200309670-00040.
Повний текст джерелаYelamanchi, Soujanya D., Sumaithangi Thattai Arun Kumar, Archita Mishra, Thottethodi Subrahmanya Keshava Prasad, and Avadhesha Surolia. "Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis." Molecules 27, no. 5 (February 24, 2022): 1520. http://dx.doi.org/10.3390/molecules27051520.
Повний текст джерелаYonetomi, Y., M. Fujita, N. Nakagawa, and T. Obata. "Preclinical pharmacology of pranlukast." Clinical & Experimental Allergy Reviews 1, no. 3 (November 2001): 210–17. http://dx.doi.org/10.1046/j.1472-9725.2001.t01-1-00008.x.
Повний текст джерела&NA;. "Pranlukast protects against deteriorating asthma control." Inpharma Weekly &NA;, no. 1086 (May 1997): 16. http://dx.doi.org/10.2165/00128413-199710860-00031.
Повний текст джерелаIikura, Y., K. Miura, Y. Odajima, T. Imai, H. Sugimoto, and M. Ebisawa. "Efficacy of pranlukast in childhood asthma." Clinical & Experimental Allergy Reviews 1, no. 3 (November 2001): 287–96. http://dx.doi.org/10.1046/j.1472-9725.2001.t01-1-00014.x.
Повний текст джерела&NA;. "Pranlukast demonstrates long-term efficacy in asthma." Inpharma Weekly &NA;, no. 1303 (September 2001): 6. http://dx.doi.org/10.2165/00128413-200113030-00015.
Повний текст джерелаKim, Sujeong, and Jong-Myung Lee. "A Case of Pranlukast-Induced Anaphylactic Shock." Allergy, Asthma & Immunology Research 8, no. 3 (2016): 276. http://dx.doi.org/10.4168/aair.2016.8.3.276.
Повний текст джерелаYang, X. X., W. S. Powell, L. J. Xu, and J. G. Martin. "Strain dependence of the airway response to dry-gas hyperpnea challenge in the rat." Journal of Applied Physiology 86, no. 1 (January 1, 1999): 152–58. http://dx.doi.org/10.1152/jappl.1999.86.1.152.
Повний текст джерелаTsuji, Yuichirou, Kenji Narui, Takaaki Takayanagi, Hiroshi Chikaoka, Seiji Takita, Youji Iikura, and Tadasu Sakai. "Effectiveness of pranlukast hydrate for Henoch-Schoenlein purpura." Nihon Shoni Jinzobyo Gakkai Zasshi 11, no. 2 (1998): 185–90. http://dx.doi.org/10.3165/jjpn.11.185.
Повний текст джерелаTheron, A. J., H. C. Steel, G. R. Tintinger, C. M. Gravett, R. Anderson, and C. Feldman. "Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function." Journal of Immunology Research 2014 (2014): 1–16. http://dx.doi.org/10.1155/2014/608930.
Повний текст джерела&NA;. "Pranlukast was found to be 'safe and well tolerated'." Reactions Weekly &NA;, no. 667 (September 1997): 4. http://dx.doi.org/10.2165/00128415-199706670-00009.
Повний текст джерелаMatsuse, Hiroto, and Shigeru Kohno. "Leukotriene receptor antagonists pranlukast and montelukast for treating asthma." Expert Opinion on Pharmacotherapy 15, no. 3 (December 19, 2013): 353–63. http://dx.doi.org/10.1517/14656566.2014.872241.
Повний текст джерелаSchurman, Scott J., Janice M. Alderman, Marc Massanari, Atilano G. Lacson, and Sharon A. Perlman. "Tubulointerstitial Nephritis Induced by the Leukotriene Receptor Antagonist Pranlukast." Chest 114, no. 4 (October 1998): 1220–23. http://dx.doi.org/10.1378/chest.114.4.1220.
Повний текст джерелаKobayashi, Shigeto, Shyugo Ishizuka, Naoto Tamura, Makiyo Takaya, Kazuhiko Kaneda, and Hiroshi Hashimoto. "Churg?Strauss syndrome (CSS) in a patient receiving pranlukast." Clinical Rheumatology 22, no. 6 (December 1, 2003): 491–92. http://dx.doi.org/10.1007/s10067-003-0791-5.
Повний текст джерелаShimbo, Junsuke, Osamu Onodera, Keiko Tanaka, and Shoji Tsuji. "Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast." Clinical Rheumatology 24, no. 6 (December 2, 2004): 661–62. http://dx.doi.org/10.1007/s10067-004-1035-z.
Повний текст джерелаSchierle, Simone, Jurema Schmidt, Astrid Kaiser, and Daniel Merk. "Selective Optimization of Pranlukast to Farnesoid X Receptor Modulators." ChemMedChem 13, no. 23 (November 20, 2018): 2530–45. http://dx.doi.org/10.1002/cmdc.201800549.
Повний текст джерелаHao, Yanli, Lan Wang, Jun Li, Nan Liu, Jinfeng Feng, Mojiao Zhao, and Xiaoning Zhang. "Enhancement of Solubility, Transport Across Madin-Darby Canine Kidney Monolayers and Oral Absorption of Pranlukast Through Preparation of a Pranlukast-Phospholipid Complex." Journal of Biomedical Nanotechnology 11, no. 3 (March 1, 2015): 469–77. http://dx.doi.org/10.1166/jbn.2015.1914.
Повний текст джерелаYoshida, Ishizaki, Shoji, Onuma, Nakagawa, Nakabayashi, Akahori, Hasegawa, and Amayasu. "Effect of pranlukast on bronchial inflammation in patients with asthma." Clinical & Experimental Allergy 30, no. 7 (July 2000): 1008–14. http://dx.doi.org/10.1046/j.1365-2222.2000.00834.x.
Повний текст джерелаSAKAGUCHI, KAZUO, JUNKO KUWABARA, AKIYO SAITOU, EMIKO MIYASHITA, YOSHIAKI TAKAYAMA, MASAHIRO AIZAKI, HISAO KUMAKURA, SHOICHI TANGE, and SHUICHI ICHIKAWA. "The Pharmacokinetic Interaction between Theophylline and Leukotriene Receptor Antagonist, Pranlukast." Japanese Journal of Hospital Pharmacy 23, no. 6 (1997): 507–11. http://dx.doi.org/10.5649/jjphcs1975.23.507.
Повний текст джерелаWatanabe, Toru, Yasufumi Iinuma, Shin-ichi Naito, and Koju Nitta. "Eosinophilic tumor in a patient with bronchial asthma receiving pranlukast." European Journal of Pediatrics 166, no. 2 (August 17, 2006): 183–84. http://dx.doi.org/10.1007/s00431-006-0226-9.
Повний текст джерелаNakade, Susumu, Akinori Yamauchi, Junji Komaba, Tomoya Ohno, Junsaku Kitagawa, Naoki Honda, Chihiro Hasegawa, et al. "Effect of Clarithromycin on the Pharmacokinetics of Pranlukast in Healthy Volunteers." Drug Metabolism and Pharmacokinetics 23, no. 6 (2008): 428–33. http://dx.doi.org/10.2133/dmpk.23.428.
Повний текст джерелаYoshifuku, Kousuke, Shoji Matsune, and Yuichi Kurono. "The Efficacy of Pranlukast Hydrate for Chronic Sinusitis with Nasal Polyp." Practica Oto-Rhino-Laryngologica 101, no. 9 (2008): 715–20. http://dx.doi.org/10.5631/jibirin.101.715.
Повний текст джерелаKim, Hyeong-Eun, Jun-Seok Hwang, Sun-Hang Cho, Young-Jin Kim, and Kang-Moo Huh. "Preparation and Characterization of Poly(ethylene glycol) Based Pranlukast Solid Dispersion." Polymer Korea 36, no. 1 (January 25, 2012): 41–46. http://dx.doi.org/10.7317/pk.2012.36.1.041.
Повний текст джерелаUNDERWOOD, D., S. BOCHNOWICZ, R. OSBORN, S. NEWSHOLME, T. TORPHY, and D. HAY. "426 The cysteinyl-leukotriene (CysLT) receptor antagonist, pranlukast, attenuates airway inflammation." Journal of Allergy and Clinical Immunology 97, no. 1 (January 1996): 289. http://dx.doi.org/10.1016/s0091-6749(96)80644-0.
Повний текст джерелаBrocks, D. R., J. W. Upward, P. Georgiou, G. Stelman, E. Doyle, E. Allen, P. Wyld, and M. J. Dennis. "The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers." European Journal of Clinical Pharmacology 51, no. 3-4 (December 12, 1996): 303–8. http://dx.doi.org/10.1007/s002280050202.
Повний текст джерелаKanazawa, Hiroshi. "Effects of Pranlukast on Vascular Endothelial Growth Factor Levels in Asthma." Chest 127, no. 4 (April 2005): 1461. http://dx.doi.org/10.1016/s0012-3692(15)34509-8.
Повний текст джерелаSun, Tao, Zhihua Wu, Mengyao Luo, Donghai Lin, and Chenyun Guo. "Pranlukast, a novel binding ligand of human Raf1 kinase inhibitory protein." Biotechnology Letters 38, no. 8 (May 5, 2016): 1375–80. http://dx.doi.org/10.1007/s10529-016-2117-0.
Повний текст джерелаKanazawa, Hiroshi. "Effects of Pranlukast on Vascular Endothelial Growth Factor Levels in Asthma." CHEST Journal 127, no. 4 (April 1, 2005): 1461. http://dx.doi.org/10.1378/chest.127.4.1461.
Повний текст джерелаBaek, In-hwan, Jung-Soo Kim, Eun-Sol Ha, Gwang-Ho Choo, Wonkyung Cho, Sung-Joo Hwang, and Min-Soo Kim. "Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose." International Journal of Biological Macromolecules 67 (June 2014): 53–57. http://dx.doi.org/10.1016/j.ijbiomac.2014.03.006.
Повний текст джерелаTakahashi, Yukitoshi, Katsumi Imai, Hitoshi Ikeda, Yuko Kubota, Etsuko Yamazaki, and Fuminobu Susa. "Open study of pranlukast add-on therapy in intractable partial epilepsy." Brain and Development 35, no. 3 (March 2013): 236–44. http://dx.doi.org/10.1016/j.braindev.2012.04.001.
Повний текст джерелаTAKAHASHI, Naotsugu, Tomoaki IWANAGA, Hisamichi AIZAWA, Hiroshi KOTO, Kentaroh WATANABE, Reiko KISHIKAWA, Togo IKEDA, Shunsuke SHOJI, Sankei NISHIMA, and Nobuyuki KARA. "Acute Interstitial Pneumonia Induced by ONO-1078 (pranlukast), a Leukotriene Receptor Antagonist." Internal Medicine 40, no. 8 (2001): 791–94. http://dx.doi.org/10.2169/internalmedicine.40.791.
Повний текст джерелаLee, Sin Hyung, Jae Jeong Shim, Kyung Kyu Kim, Hye Cheol Jeong, Young Hwan Kwon, Je Hyeong Kim, Sung Yong Lee, et al. "Effects of pranlukast on ovalbumin induced early-phase bronchoconstriction in guinea pigs." Tuberculosis and Respiratory Diseases 46, no. 5 (1999): 697. http://dx.doi.org/10.4046/trd.1999.46.5.697.
Повний текст джерелаKOBAYASHI, Maiko, Takako MASUDA, Yusuke KINOSHITA, and Hiroyuki HARA. "Churg-Strauss Syndrome in a Patient Receiving Pranlukast as Treatment for Asthma." Nishi Nihon Hifuka 67, no. 4 (2005): 319–22. http://dx.doi.org/10.2336/nishinihonhifu.67.319.
Повний текст джерелаEndo, Shuichiro, Minoru Gotoh, Kimihiro Okubo, Kazuhiro Hashiguchi, Hidenori Suzuki, and Keisuke Masuyama. "Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber." Journal of Drug Assessment 1, no. 1 (February 22, 2012): 48–54. http://dx.doi.org/10.3109/21556660.2012.703630.
Повний текст джерелаVelázquez-Quesada, Inés, Angel J. Ruiz-Moreno, Diana Casique-Aguirre, Charmina Aguirre-Alvarado, Fabiola Cortés-Mendoza, Marisol de la Fuente-Granada, Carlos García-Pérez, et al. "Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells." Drug Design, Development and Therapy Volume 14 (May 2020): 1799–811. http://dx.doi.org/10.2147/dddt.s247730.
Повний текст джерелаIchiyama, T., S. Hasegawa, M. Umeda, K. Terai, T. Matsubara та S. Furukawa. "Pranlukast inhibits NF-κB activation in human monocytes/macrophages and T cells". Clinical & Experimental Allergy 33, № 6 (червень 2003): 802–7. http://dx.doi.org/10.1046/j.1365-2222.2003.01673.x.
Повний текст джерелаInoue, Ryosuke, Takahide Teramoto, Susumu Nakade, Hiroyuki Okamoto, Eiji Yukawa, Shun Higuchi, Naomi Kondo, and Haruki Mikawa. "Population pharmacokinetics of pranlukast hydrate dry syrup in children with bronchial asthma." Allergology International 52, no. 4 (2003): 213–18. http://dx.doi.org/10.1046/j.1323-8930.2003.00304.x.
Повний текст джерелаHoriguchi, Takahiko, Soichi Tachikawa, Rieko Kondo, Junichi Miyazaki, Yasushi Sasaki, Kengo Banno, and Misuzu Handa. "Evaluation of the Combined Effect of Pranlukast during High-dose Steroid Inhalation." Arzneimittelforschung 52, no. 11 (December 26, 2011): 813–16. http://dx.doi.org/10.1055/s-0031-1299972.
Повний текст джерелаNagata, Makoto, Keiko Saito, Izumi Kikuchi, Koichi Hagiwara, and Minoru Kanazawa. "Effect of the Cysteinyl Leukotriene Antagonist Pranlukast on Transendothelial Migration of Eosinophils." International Archives of Allergy and Immunology 137, no. 1 (2005): 2–6. http://dx.doi.org/10.1159/000085424.
Повний текст джерела